VXRT - アビラジェン・セラピュ―ティクス (Vaxart Inc.)

VXRTのニュース

   Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst  2021/03/12 02:05:50 ADVFN UK
The stock market has been pulled aggressively in both directions in 2021, but the moves are relatively tame compared to the wild ride of…
   Bireme Capital: “Vaxart, Inc. is Exhibiting Classic Pretender Signals”  2021/03/05 15:11:27 Yahoo Finance
Bireme Capital, an investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 47.1% was recorded by the fund for the year end 2020, outperforming its S&P500 benchmark that delivered an 18.3% return. You can view the fund’s top 5 holdings to have a […]
   State Street Corporation Reports In 13G Filing An 8.63% In Vaxart  2021/02/11 13:33:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   Vaxart shares tank following release of preliminary Phase 1 data for oral COVID-19 vaccine tablet – Microbial Biotech News  2021/02/04 16:46:08 Microbial Biotech News
Shares of Vaxart, Inc., (NASDAQ: VXRT) tanked this week following the company’s announcement of preliminary data from the Phase 1 study of its oral tablet COVID-19 vaccine, VXA-CoV2-1
   Vaxart Tanks 58% On Oral COVID-19 Vaccine Early Trial Data; Street Says Buy  2021/02/04 08:13:54 Smarter Analyst
Shares of Vaxart cratered 58% on Feb. 3 after early preliminary trial data showed that its oral COVID-19 vaccine did not produce neutralizing … The post Vaxart Tanks 58% On Oral COVID-19 Vaccine Early Trial Data; Street Says Buy appeared first on Smarter Analyst .
   Vaxart: The ‘Show Me’ Story Still Has Potential, Says Analyst  2021/03/12 02:05:50 ADVFN UK
The stock market has been pulled aggressively in both directions in 2021, but the moves are relatively tame compared to the wild ride of…
   Bireme Capital: “Vaxart, Inc. is Exhibiting Classic Pretender Signals”  2021/03/05 15:11:27 Yahoo Finance
Bireme Capital, an investment management firm, published its fourth-quarter 2020 Investor Letter – a copy of which can be downloaded here. A net return of 47.1% was recorded by the fund for the year end 2020, outperforming its S&P500 benchmark that delivered an 18.3% return. You can view the fund’s top 5 holdings to have a […]
   State Street Corporation Reports In 13G Filing An 8.63% In Vaxart  2021/02/11 13:33:00 Benzinga
This headline-only article is meant to show you why a stock is moving, the most difficult aspect of stock trading. Every day we publish hundreds of …
   Vaxart shares tank following release of preliminary Phase 1 data for oral COVID-19 vaccine tablet – Microbial Biotech News  2021/02/04 16:46:08 Microbial Biotech News
Shares of Vaxart, Inc., (NASDAQ: VXRT) tanked this week following the company’s announcement of preliminary data from the Phase 1 study of its oral tablet COVID-19 vaccine, VXA-CoV2-1
   Vaxart Tanks 58% On Oral COVID-19 Vaccine Early Trial Data; Street Says Buy  2021/02/04 08:13:54 Smarter Analyst
Shares of Vaxart cratered 58% on Feb. 3 after early preliminary trial data showed that its oral COVID-19 vaccine did not produce neutralizing … The post Vaxart Tanks 58% On Oral COVID-19 Vaccine Early Trial Data; Street Says Buy appeared first on Smarter Analyst .

calendar